TANGULER TOLGA (EVP, Chief Commercial Officer) sold 4.2% of their position (1.60K shares) of ALNYLAM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $523.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+4.77K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−47.00
Price / share
$323.62
Trade value
$15.21K
% of position
Common Stock
Shares
−90.00
Price / share
$324.65
Trade value
$29.22K
% of position
Common Stock
Shares
−258.00
Price / share
$325.63
Trade value
$84.01K
% of position
Common Stock
Shares
−392.00
Price / share
$326.81
Trade value
$128.11K
% of position
Common Stock
Shares
−329.00
Price / share
$327.67
Trade value
$107.80K
% of position
Common Stock
Shares
−100.00
Price / share
$328.71
Trade value
$32.87K
% of position
Common Stock
Shares
−170.00
Price / share
$329.71
Trade value
$56.05K
% of position
Common Stock
Shares
−81.00
Price / share
$330.85
Trade value
$26.80K
% of position
Common Stock
Shares
−94.00
Price / share
$331.93
Trade value
$31.20K
% of position
Common Stock
Shares
−37.00
Price / share
$332.64
Trade value
$12.31K
% of position
Net shares
+3.17K
Net value
-$523.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +4.77K | — | — | 14.3% | 33.44K | 38.20K |
| Common Stock Direct | 3/2/2026 | S · Sale | −47.00 | $323.62 | $15.21K | 0.1% | 38.20K | 38.16K |
| Common Stock Direct | 3/2/2026 | S · Sale | −90.00 | $324.65 | $29.22K | 0.2% | 38.16K | 38.07K |
| Common Stock Direct | 3/2/2026 | S · Sale | −258.00 | $325.63 | $84.01K | 0.7% | 38.07K | 37.81K |
| Common Stock Direct | 3/2/2026 | S · Sale | −392.00 | $326.81 | $128.11K | 1.0% | 37.81K | 37.42K |
| Common Stock Direct | 3/2/2026 | S · Sale | −329.00 | $327.67 | $107.80K | 0.9% | 37.42K | 37.09K |
| Common Stock Direct | 3/2/2026 | S · Sale | −100.00 | $328.71 | $32.87K | 0.3% | 37.09K | 36.99K |
| Common Stock Direct | 3/2/2026 | S · Sale | −170.00 | $329.71 | $56.05K | 0.5% | 36.99K | 36.82K |
| Common Stock Direct | 3/2/2026 | S · Sale | −81.00 | $330.85 | $26.80K | 0.2% | 36.82K | 36.74K |
| Common Stock Direct | 3/2/2026 | S · Sale | −94.00 | $331.93 | $31.20K | 0.3% | 36.74K | 36.64K |
| Common Stock Direct | 3/2/2026 | S · Sale | −37.00 | $332.64 | $12.31K | 0.1% | 36.64K | 36.61K |
| Total | +3.17K | -$523.58K | ||||||
Stock Option (right to buy)
Common Stock
10.48K shares
Shares
+10.48K
Strike price
325.07
Held after
10.48K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10.48K shares | 3/2/2026 | A · Award | +10.48K | 325.07 | — | 10.48K |